go-e GmbH: Türkiye elektromobilite için Avrupa’nın yeni sıcak noktası
Araştırma: Türkiye’deki elektrikli otomobil sürücüleri genç, şehirli, eğitimli ve evde şarj etmeyi giderek daha fazla keşfediyor. Markalı ürünler ve çok işlevli çözümler özellikle popüler. ISTANBUL, 9 Temmuz 2025 /PRNewswire/ — Türkiye’de elektromobilite hızla gelişiyor: 2016 yılında sadece 44 e-araç yeni tescil edilmişken, bu rakam 2024 yılına kadar 105.000’in üzerine çıktı. 2025’in ortalarına gelindiğinde ise yaklaşık […]
Kuwait International Bank Enhances Self-Service Banking with Diebold Nixdorf Technology
Interactive Teller Machines (ITMs) offer expanded services and convenience to customers NORTH CANTON, Ohio, July 9, 2025 /PRNewswire/ — Diebold Nixdorf (NYSE: DBD), a global leader in transforming the way people bank and shop, announced today the successful implementation of its Interactive Teller Machines (ITMs) at Kuwait International Bank (KIB). This strategic deployment is a significant […]
La Lucid Air Grand Touring remporte le titre de GUINNESS WORLD RECORDS™ avec 1 205 kilomètres en une seule charge
« Ce record d’autonomie est une étape importante – il s’agit d’une nouvelle démonstration de l’avance technologique qui caractérise Lucid », déclare Eric Bach, vice-président senior des produits et ingénieur en chef chez Lucid. « Nos produits Lucid combinent une efficacité automobile de classe mondiale avec les unités de propulsion, l’architecture à ultra-haute tension et la technologie de […]
Arcadia Cognerati contrata a Daniel Chávez como vicepresidente de Innovación en Capacitación y Desempeño
NUEVA YORK, 9 de julio de 2025 /PRNewswire-HISPANIC PR WIRE/ — Arcadia Cognerati, la autoridad líder en Reconocimiento y Análisis de Patrones de Comportamiento Humano (HBPR&A), anunció hoy el nombramiento de Daniel Chávez como su nuevo vicepresidente de Innovación en aCapacitación y Desempeño, a partir del 8 de julio de 2025. En este papel fundamental, […]
CGTN: Why does China honor the spirit of resisting aggression?
BEIJING, July 9, 2025 /PRNewswire/ — CGTN has published an article on why China will commemorate the 80th anniversary of its victory in the Chinese People’s War of Resistance Against Japanese Aggression and the World Anti-Fascist War, and how the country has drawn strength from its past to power modernization. The Hundred-Regiment Campaign was the […]
China Telecom Day Successfully Unveiled at China Pavilion, Expo 2025 Osaka
HONG KONG, July 9, 2025 /PRNewswire/ — On July 4, the China Telecom Day titled “Empowering an Intelligent Future” officially commenced with a grand opening at the China Pavilion, Expo 2025 Osaka, Japan. At the Osaka World Expo, the China Pavilion, with its unique charm and profound connotations, tells the stories of China to the […]
CGTN: Why does China honor the spirit of resisting aggression?
BEIJING, July 9, 2025 /PRNewswire/ — CGTN has published an article on why China will commemorate the 80th anniversary of its victory in the Chinese People’s War of Resistance Against Japanese Aggression and the World Anti-Fascist War, and how the country has drawn strength from its past to power modernization. The Hundred-Regiment Campaign was the […]
Regent Hong Kong Named the #1 City Hotel in Asia, #1 City Hotel in Hong Kong and #14 Globally at Travel + Leisure World’s Best Awards 2025
High-resolution images: Regent Hong Kong Digital Access HONG KONG, July 9, 2025 /PRNewswire/ — Renowned as a majestic haven of discreet luxury on Victoria Harbour, Regent Hong Kong is honoured to be voted the #1 City Hotel in Asia – topping the list in the 2025 edition of the prestigious Travel + Leisure World Best […]
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
SHANGHAI, July 9, 2025 /PRNewswire/ — Duality Biotherapeutics’ (“DualityBio”, HKEX:09606) partner Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the first patient has been dosed in the Phase 1 portion of a Phase 1/2 clinical study evaluating AVZO-1418/DB-1418, a potential best-in-class, novel EGFR/HER3 bispecific antibody-drug conjugate (ADC), in patients […]
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418
SHANGHAI, July 8, 2025 /PRNewswire/ — Duality Biotherapeutics’ (“DualityBio”, HKEX:09606) partner Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the first patient has been dosed in the Phase 1 portion of a Phase 1/2 clinical study evaluating AVZO-1418/DB-1418, a potential best-in-class, novel EGFR/HER3 bispecific antibody-drug conjugate (ADC), in patients […]